Andere talen Ondine Biomedical Inc.

Aandelen

Beurs gesloten - London S.E. Andere beurzen 17:35:05 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
5,875 ^GBX	0,00%		-12,96%	-32,86%

22/04	Ondine Biomedical viert gebruik van Steriwave in Australisch ziekenhuis	AN
22/04	Mater Hospital gebruikt Ondine Biomedical's bekroonde licht-geactiveerde antimicrobiële technologie	CI

Ondine Biomedical - Corporate and Trading Update	25/04
EARNINGS AND TRADING: Nichols trading in line; Ondine revenue doubles	24/04
Ondine Biomedical celebrates use of Steriwave in Australian hospital	22/04
Mater Hospital, to Use Ondine Biomedical's Award-Winning Light-Activated Antimicrobial Technology	22/04
Ondine Biomedical's Steriwave reduces SSI's by 32%, study shows	15/04
Ondine Biomedical shares jump as Steriwave approved by HCA Healthcare	10/04
HCA Healthcare UK Approves the Steriwave Light-Activated Antimicrobial Developed by Ondine Biomedical Inc	10/04
Ondine says introduction of Steriwave in ICU market could boost sales	04/04
Ondine Biomedical Inc. Prepares to Enter the Intensive Care Unit Market	04/04
Ondine Biomedical's Finance Chief Resigns; Interim CFO Named	28/03
Ondine Biomedical appoints new interim chief financial officer	28/03
Ondine Biomedical Inc. Announces Executive Appointments	28/03
Ondine Biomedical Inc. Announces Chief Financial Officer Changes	28/03
Ondine Biomedical achieves milestone with NHS trust's adoption of Steriwave	27/03
Ondine Biomedical Inc. - First commercial adoption of Steriwave by the NHS	26/03
Peel Hunt's RetailBook raises GBP2.5 million	25/03
Ondine Biomedical Wins First NHS Commercial Deal for Steriwave Treatment	25/03
Ondine Biomedical Inc. Announces Steriwave Study Shows 77% Drop in Antibody Use	21/03
Ondine Biomedical says commercial progress ahead of forecast	15/03
Ondine Biomedical Inc. Announces Steriwave Deploying in Eight New Sites	15/03

Geen resultaten voor deze zoekopdracht